Kirin Holdings Company, Limited

Overview

1. "How the company got here" Kirin Holdings Company, Limited has a long history, with its origins tracing back to the Japan Brewery Company, founded in 1885. It was officially established as Kirin Brewery Company in 1907. The company experienced significant growth in Japan's post-war economic boom, particularly in the beer market. Over time, Kirin expanded beyond its core brewing business, diversifying into food and beverages, and later venturing into pharmaceuticals in the 1980s. In 2007, it transitioned to a holding company structure, becoming Kirin Holdings Company, Limited, to better manage its diverse operations. 2. "What it actually does" Kirin Holdings is a Japanese company that operates in several key areas: alcoholic beverages, non-alcoholic beverages and health science, and pharmaceuticals. While it's widely known for its beer brands, the company has a broader portfolio that includes soft drinks, dairy products, and health-focused products. Kirin leverages its expertise in fermentation and biotechnology, which originated from its brewing business, to develop products across these different sectors. 3. "Alcoholic Beverages" This segment is the historical core of Kirin's business and includes a wide range of alcoholic drinks. It encompasses well-known beer brands like Kirin Ichiban and Kirin Lager, as well as other alcoholic beverages such as wine and spirits produced by subsidiaries like Mercian Corporation. Kirin's brewing operations extend globally, with a significant presence in Asia and Oceania, and it also distributes some international brands in Japan. This part of the business is a major contributor to Kirin's overall revenue. 4. "Non-alcoholic Beverages & Health Science" This growing segment focuses on beverages that are not alcoholic, as well as products aimed at health and well-being. It includes popular soft drinks like Kirin Lemon and various tea beverages. More recently, Kirin has been expanding its health science offerings, which include functional foods and supplements designed to support areas like immune function, using proprietary ingredients like Lactococcus lactis strain Plasma. This segment aims to create value by encouraging healthier lifestyle habits among consumers. 5. "Pharmaceuticals" Kirin has a dedicated pharmaceuticals business that develops and sells prescription drugs. This segment leverages the company's biotechnology expertise, particularly in areas like antibody therapeutics and gene therapy. The pharmaceutical division has grown into a global operation for Kirin, contributing to its diverse business portfolio. 6. "What management is betting on now" Kirin's current strategy, outlined in its "Innovate2035!" long-term vision, is centered on driving innovation to create new lifestyle habits in food and health. The company aims to be a global leader in "Creating Shared Value" (CSV), which means generating both social and economic benefits. Management is focusing on strengthening its Non-alcoholic Beverages & Health Science domain, integrating acquisitions like FANCL to achieve synergies, and continuing to invest in research and development for its pharmaceutical business. The goal is to achieve sustainable growth by balancing its diverse business portfolio and focusing on areas that support consumer well-being.